본문 바로가기
KERD
논문KCI 등재

뇌졸중 후 우울증에 대한 천왕보심단의 유효성 및 안전성 연구 : 무작위 배정, 이중맹검, 비열등성 연구

Study of Efficacy and Safety of Tianwangbuxin-dan for Poststroke Depression: A Randomized, Double Blinded, Non-inferiority Trial

김문수|이상관|이일석
대한한방내과학회 (The Society Of Korean Oriental Internal Medicine)|2014.06|대한한방내과학회지 (The Journal of Korean Oriental Internal Medicine)|제35권 제2호|pp. 145-156

1

조회

0

다운로드

4

인용

0

참고문헌

키워드

FluoxetineTianwangbuxin-danpoststroke depressionBeck’s depression inventoryHamilton depression rating scale
주제분류한의학

초록

Objectives : The aim of this study was to compare Tianwangbuxin-dan to Fluoxetine for antidepressive efficacy and safety in poststroke depression (PSD). Methods : A randomized, double blinded, non-inferiority trial was conducted. 113 PSD patients were recruited from a stroke center. Except for the 25 excluded patients, 88 PSD patients were randomly given either Tianwangbuxin-dan 1100 mg or Fluoxetine 20 mg per a day for 16 weeks. PSD was evaluated using Beck’s depression inventory (BDI) and Hamilton depression rating scale (HDRS) and followed every fourth week. Repeated measure analysis of variance (ANOVA) was used to compare and contrast the depression scores of the two groups and to compare them among the evaluation times, at the beginning, 4th, 8th, 12th and 16th weeks. In addition, independent t-tests were used to find the difference between two groups at every evaluation time. Results : Finally, 88 PSD patients were included in the study, 63 PSD patients completed the procedure and 25 PSD patients were dropped out by the incompliance or withdrawal of consent. Tianwangbuxin-dan (or Fluoxetine) improved the depression of stroke patients and the efficacy of Tianwangbuxin-dan was not inferior to that of Fluoxetine. In addition, there was no significant side effect in two groups. Conclusions : This study showed that antidepressive efficacy and safety of Tianwangbuxin-dan in PSD patients.

Abstract

Objectives : The aim of this study was to compare Tianwangbuxin-dan to Fluoxetine for antidepressive efficacy and safety in poststroke depression (PSD). Methods : A randomized, double blinded, non-inferiority trial was conducted. 113 PSD patients were recruited from a stroke center. Except for the 25 excluded patients, 88 PSD patients were randomly given either Tianwangbuxin-dan 1100 mg or Fluoxetine 20 mg per a day for 16 weeks. PSD was evaluated using Beck’s depression inventory (BDI) and Hamilton depression rating scale (HDRS) and followed every fourth week. Repeated measure analysis of variance (ANOVA) was used to compare and contrast the depression scores of the two groups and to compare them among the evaluation times, at the beginning, 4th, 8th, 12th and 16th weeks. In addition, independent t-tests were used to find the difference between two groups at every evaluation time. Results : Finally, 88 PSD patients were included in the study, 63 PSD patients completed the procedure and 25 PSD patients were dropped out by the incompliance or withdrawal of consent. Tianwangbuxin-dan (or Fluoxetine) improved the depression of stroke patients and the efficacy of Tianwangbuxin-dan was not inferior to that of Fluoxetine. In addition, there was no significant side effect in two groups. Conclusions : This study showed that antidepressive efficacy and safety of Tianwangbuxin-dan in PSD patients.

참고문헌 (43)

  1. Kauhanen ML, "Aphasia, depression, and non-verbal cognitive impairment in ischaemic stroke", Cerebrovasc Dis, 10(6), pp.455~461 (2000)
  2. Robinson RG, "Poststroke depression: prevalence, diagnosis, treatment, and disease progression", Biol Psychiatry, 54(3), pp.376~387 (2003)
  3. House A, "The relationship between intellectual impairment and mood disorder in the first year after stroke. 4. Spalletta G, Guida G, De Angelis D, Caltagirone C. Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness", J Neurol, 249(11), pp.1541~1551 (2002)
  4. Paolucci S, "Post-stroke depression, antidepressant treatment and rehabilitation results", Cerebrovasc Dis, 12(3), pp.264~271 (2001)
  5. Lipsey J, "Nortriptyline treatment of post-stroke depression: a double-blind study", The Lancet, 323(8372), pp.297~300 (1984)
  6. Andersen G, "Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram", Stroke, 25(6), pp.1099~1104 (1994)
  7. Wiart L, "Fluoxetine in Early Poststroke Depression A Double-Blind Placebo-Controlled Study", Stroke, 31(8), pp.1829~1832 (2000)
  8. Chemerinski E, "Improved recovery in activities of daily living associated with remission of poststroke depression", Stroke, 32(1), pp.113~117 (2001)
  9. Chollet F, "Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial", Lancet Neurol, 10(2), pp.123~130 (2011)
  10. Jorge RE, "Mortality and poststroke depression: a placebo- controlled trial of antidepressants", Am J Psychiatry, 160(10), pp.1823~1829 (2003)
  11. Yi Z, "Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta‐analysis", Int J Clin Pract, 64(9), pp.1310~1317 (2010)
  12. Robinson RG, "Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial", JAMA, 299(20), pp.2391~2400 (2008)
  13. Stamenkovic M, "Therapy of post-stroke depression with fluoxetine", A pilot project. Nervenarzt, 67(1), pp.62~67 (1996)
  14. Li LT, "The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depression", J Altern Complement Med, 14(7), pp.841~846 (2008)
  15. González-Torrecillas JL, "Effects of early treatment of poststroke depression on neuropsychological rehabilitation", Int Psychogeriatr, 7(04), pp.547~560 (1995)
  16. Chen W, "Study of effect of integrative Chinese herbs with fluoxetine on rehabilitation of neurological impairment in patients with post-stroke depression", Journal of Chengdu University of Traditional Chinese Medicine, 24(4), pp.20~ (2001)
  17. Paolucci S, "Epidemiology and treatment of post-stroke depression", Neuropsychiatr Dis Treat, 4(1), pp.145~ (2008)
  18. Mead GE, "Selective Serotonin Reuptake Inhibitors for Stroke Recovery A Systematic Review and Meta-analysis", Stroke, 44(3), pp.844~850 (2013)
  19. Murray V, "Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression", J Clin Psychiatry, 66(6), pp.805~814 (2005)
  20. Robinson RG, "Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study", Am J Psychiatry, 157(3), pp.351~359 (2000)
  21. 이상택, "三精丸의 항우울 효과에 대한 실험적 연구", 동의신경정신과학회지, 19(3), pp.101~116 (2008), 대한한방신경정신과학회
  22. 강형원, "우울증(憂鬱症) 의 한방적(韓方的) 이해(理解) 에 관한 문헌고찰(文獻考察)", 동의신경정신과학회지, 12(2), pp.1~15 (2001)
  23. 이일석, "뇌졸중 후 우울증과 한열허실 변증의 상관관계", 대한한방내과학회지, 35(1), pp.50~58 (2014), 대한한방내과학회
  24. 최지혜, "뇌졸중후 우울증 침치료의 임상연구에 대한 고찰", 동의생리병리학회지, 25(6), pp.1119~1128 (2011), 대한동의병리학회
  25. 선종주, "중풍후우울증 환자에 대한 향기침요법의 임상적 연구", 대한한방내과학회지, 27(2), pp.480~487 (2006), 대한한방내과학회
  26. 제준태, "뇌졸중 후 우울증에 대한 황련해독탕 약침의 안전성 및 유효성 평가를 위한 임상 시험", Journal of Pharmacopuncture, 13(2), pp.67~74 (2010), 대한약침학회
  27. 나병조, "중풍후우울증에 대한 반하후박탕의 유효성 및 적응증 평가", 대한한방내과학회지, 26(3), pp.563~574 (2005), 대한한방내과학회
  28. 성강경, "Effects of Electro-Acupuncture Therapy on Post-Stroke Depression in Patients with Different Degrees of Motor Function Impairments: a Pilot Study", JOURNAL OF PHYSICAL THERAPY SCIENCE, 25(3), pp.725~728 (2013), Society of Physical Therapy Science
  29. Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4(6), pp.561~ (1961)
  30. Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23(1), pp.56~ (1960)
  31. Choi-Kwon S, "Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness a double-blind, placebo- controlled study", Stroke, 37(1), pp.156~161 (2006)
  32. Weng S, "Comparison of the Addition of Siberian Ginseng (Acanthopanax senticosus) Versus Fluoxetine to Lithium for the Treatment of Bipolar Disorder in Adolescents: A Randomized, Double-Blind Trial", Current Therapeutic Research, 68(4), pp.280~290 (2007)
  33. "천심액(천왕보심단)"[URL]
  34. "푸로작캡슐20밀리그램(플루옥세틴염산염)"[URL]
  35. 危亦林, "世醫得效方", pp.217~ (1990), 醫聖堂
  36. 허준, "(對譯)東醫寶鑑", pp.205~ (1999), 법인문화사
  37. 呂光榮, "中醫腦病證治", pp.72~81 (1991), 과학기술문헌출판사
  38. 박종흠, "천왕보심단(天王補心丹)의 항우울효과 및 monoamine 대사에 미치는 영향", 대한한의학방제학회지, 12(2), pp.77~93 (2004)
  39. Chen Q, "The Clinical and pharmacology of the Chinese patent medicine", pp.342~359 (1998), Ren Min Wei Min Chu Ban She
  40. Fruehwald S, "Early fluoxetine treatment of post-stroke depression", J Neurol, 250(3), pp.347~351 (2003)
  41. Huffman J, "Acute psychiatric manifestations of stroke: a clinical case conference", Psychosomatics, 44(1), pp.65~75 (2003)
  42. Robinson RG, "Poststroke depression: a review", Can J Psychiatry, 55(6), pp.341~ (2010)
  43. 김남재, "생약복합제제(生藥複合製劑)의 약효연구(藥效硏究)(제37보)(第37報) -천왕보심단(天王補心丹)이 중추신경계(中樞神經系) 및 순환기계(循環器系)에 미치는 영향(影響)", 생약학회지, 19(3), pp.208~215 (1988)

관련 논문AI추천

뇌졸중 후 우울증 : 한방 치료에 대한 국내외 최신 문헌 고찰백경민, 이제원, 장우석, 황하연, 이보매나대한한방내과학회 · 대한한방내과학회지2012 · 제33권 제4호뇌졸중 후 우울증에 대한 황련해독탕 약침의 안전성 및 유효성 평가를 위한 임상 시험이상관, 제준태대한약침학회 · Journal of Pharmacopuncture2010 · 제13권 제2호중풍후우울증에 대한 월국환의 효과와 안전성: 체계적 문헌고찰 및 메타분석김병진, 김상호대한한방신경정신과학회 · 동의신경정신과학회지2024 · 제35권 제4호뇌졸중 후 우울증에 대한 침과 한약의 결합 치료 효과: 체계적 문헌 고찰 및 메타분석 연구김상호, 임수연, 정대규, 사공종원대한한방신경정신과학회 · 동의신경정신과학회지2020 · 제31권 제3호뇌졸중 후 우울증에 대한 감맥대조탕(甘麥大棗湯)의 효과: 체계적 문헌 고찰 및 메타 분석김경민, 김영균, 김예슬, 이영서대한한방내과학회 · 대한한방내과학회지2024 · 제45권 제3호주요우울장애에 대한 한약 단독치료의 효과와 안전성: 체계적문헌고찰 및 메타분석권희주, 김상호, 승혜빈대한한방신경정신과학회 · 동의신경정신과학회지2022 · 제33권 제1호

이 간행물의 다른 논문 (8건)

중국, 일본, 한국, WHO의 한약 자발적부작용보고체계 현황정수연, 우연주, 박병주pp. 111-118고지방 식이로 유발된 고지혈증 동물 모델에서 四物活血湯의 효과 연구조재준, 전상윤, 강성순, 신용진pp. 119-132白花蛇舌草, 山慈姑, 浙貝母에 의한 MDA-MB-231 인체 유방암 세포에서의 항암 효과심원석, 최영현, 진명호, 허희수, 홍상훈, 강유경, 박철, 박상은, 박선영pp. 133-144기능성 소화불량 환자에서 설태후박 및 흉늑각 측정의 진단적 가치김진성, 손지영pp. 157-174비알코올성 지방간 세포 모델에서 곤포의 효능과 기전 연구최준용, 한창우, 권민정, 홍진우, 박성하, 이인, 권정남, 김소연, 주명수pp. 175-183
원문 보기